Be the first to like this
"How have reimbursement policies changed Poland’s pharma and healthcare markets?
Market report details results, explores forecasts for development to 2015.
Implementation of the provisions of Poland’s Reimbursement Act has created visible consequences in the country’s pharmaceutical and healthcare markets. The experienced analysts at PMR have kept close watch on these changes, observing events and collecting data that documents variations in sales values of various medications, the value of the hospital market and best-selling medicines across the industry.